Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

Conditions

• Rheumatoid Arthritis

Interventions

• OTHER: Placebo
• BIOLOGICAL: Certolizumab pegol

Sponsor

UCB Pharma